Hypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma

Kang,Fei-Wu; Gao,Yin; Que,Lin; Sun,Jing; Wang,Zuo-Lin

doi:10.3892/etm.2012.779

Hypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma

Authors:
- Fei-Wu Kang
- Yin Gao
- Lin Que
- Jing Sun
- Zuo-Lin Wang
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Tongji University, Shanghai 200072, P.R. China, Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Wenzhou Medical College, Wenzhou 325035, P.R. China
Published online on: October 30, 2012 https://doi.org/10.3892/etm.2012.779
Pages: 112-118

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the expression of hypoxia-inducible factor‑1α (HIF‑1α) in tongue squamous cell carcinoma (TSCC) and to assess its possible impact on prognosis. A total of 49 tumor samples and 15 adjacent non‑tumor samples from 49 patients treated between January 2000 and December 2005 at the Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Tongji University (Shanghai, China) were obtained for investigation with immunohistochemistry and reverse transcription‑polymerase chain reaction (RT‑PCR). The expression of HIF‑1α was detected in 87.76% (43/49) of the TSCC samples and in 33.33% (5/15) of the adjacent non‑tumor tissues. The expression of vascular endothelial growth factor (VEGF) was also observed in 83.67% (41/49) of the TSCC samples and in only 20% (3/15) of the adjacent non‑tumor samples at a low level. RT‑PCR revealed that the mRNA expression of HIF‑1α and VEGF was present in the tumor tissues; however, it was barely detected in the corresponding adjacent normal tissues. The overexpression of HIF‑1α was significantly associated with T classification (P=0.01), lymphatic metastasis (P=0.05) and histological differentiation (P<0.001). Furthermore, HIF‑1α overexpression was significantly associated with poor overall (P=0.001) and disease‑free survival rates (P=0.01), independent of T stage and lymphatic metastasis. The Cox proportional hazards regression model demonstrated that the level of HIF‑1α expression may be an independent prognostic factor for TSCC. HIF‑1α overexpression was observed in TSCC and its overexpression suggests a poor prognosis. HIF‑1α may be a molecular marker for predicting the prognosis of TSCC.

View Figures

View References

1	Hochachka PW: Mechanism and evolution of hypoxia-tolerance in humans. J Exp Biol. 201:1243–1254. 1998.PubMed/NCBI
2	Vaupel P, Thews O and Hoeckel M: Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol. 18:243–259. 2001. View Article : Google Scholar : PubMed/NCBI
3	Nakayama K, Kanzaki A, Hata K, et al: Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett. 176:215–223. 2002. View Article : Google Scholar : PubMed/NCBI
4	Kuwai T, Kitadai Y, Tanaka S, et al: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer. 105:176–181. 2003. View Article : Google Scholar : PubMed/NCBI
5	Ioannou M, Mylonis I, Kouvaras E, et al: Validated analysis of HIF-1α expression in cancer cells using a controlled and comparative immunoassay. Oncol Rep. 24:161–169. 2010.
6	Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O₂ tension. Proc Natl Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
7	Salceda S and Caro J: Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 272:22642–22647. 1997. View Article : Google Scholar
8	Wang GL and Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA. 90:4304–4308. 1993. View Article : Google Scholar : PubMed/NCBI
9	Krieg M, Haas R, Brauch H, Acker T, Flamme I and Plate KH: Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 19:5435–5443. 2000. View Article : Google Scholar
10	Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr and Goldberg MA: Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA. 93:10595–10599. 1996. View Article : Google Scholar : PubMed/NCBI
11	Bianco F, Basini G, Santini S and Grasselli F: Angiogenic activity of swine granulosa cells: effects of hypoxia and the role of VEGF. Vet Res Commun. 29(Suppl 2): 157–159. 2005. View Article : Google Scholar : PubMed/NCBI
12	Choi SB, Park JB, Song TJ and Choi SY: Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line. Int J Mol Med. 28:449–454. 2011.PubMed/NCBI
13	Yasuda S, Arii S, Mori A, et al: Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol. 40:117–123. 2004. View Article : Google Scholar : PubMed/NCBI
14	Takahashi R, Tanaka S, Hiyama T, et al: Hypoxia-inducible factor-1α expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep. 10:797–802. 2003.
15	Giatromanolaki A, Koukourakis MI, Sivridis E, et al: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer. 85:881–890. 2001. View Article : Google Scholar : PubMed/NCBI
16	Casiglia J and Woo SB: A comprehensive review of oral cancer. Gen Dent. 49:72–82. 2001.
17	Wittekind C, Compton CC, Greene FL and Sobin LH: TNM residual tumor classification revisited. Cancer. 94:2511–2516. 2002. View Article : Google Scholar : PubMed/NCBI
18	Gordan JD and Simon MC: Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev. 17:71–77. 2007. View Article : Google Scholar : PubMed/NCBI
19	Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol. 35:71–103. 2000. View Article : Google Scholar : PubMed/NCBI
20	Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
21	Richard DE, Berra E and Pouysségur J: Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun. 266:718–722. 1999. View Article : Google Scholar : PubMed/NCBI
22	Kyzas PA, Stefanou D, Batistatou A and Agnantis NJ: Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 131:624–630. 2005. View Article : Google Scholar : PubMed/NCBI
23	Vidal O, Soriano-Izquierdo A, Pera M, et al: Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg. 12:1005–1014. 2008. View Article : Google Scholar
24	Zhao ZQ, Yang S and Lu HS: Expression of midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival. Mol Med Report. 5:415–419. 2012.PubMed/NCBI
25	Sugiura T, Inoue Y, Matsuki R, et al: VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker. Int J Oncol. 34:673–680. 2009. View Article : Google Scholar : PubMed/NCBI
26	Shibaji T, Nagao M, Ikeda N, et al: Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res. 23:4721–4727. 2003.PubMed/NCBI
27	Gruber G, Greiner RH, Hlushchuk R, et al: Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res. 6:R191–R198. 2004. View Article : Google Scholar : PubMed/NCBI
28	Lu XG, Xing CG, Feng YZ, Chen J and Deng C: Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer. 5:350–353. 2006. View Article : Google Scholar : PubMed/NCBI
29	Birner P, Schindl M, Obermair A, Plank C, Breitenecker G and Oberhuber G: Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60:4693–4696. 2000.PubMed/NCBI
30	Bos R, van der Groep P, Greijer AE, et al: Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer. 97:1573–1581. 2003. View Article : Google Scholar : PubMed/NCBI
31	Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U and Buerger H: HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer. 5:842005. View Article : Google Scholar : PubMed/NCBI